> Integrating basic science and clinical research to develop promising detection techniques and treatments for prostate disease

The CPDR mission is fulfilled primarily through its three principal programs – the Clinical Research Program, the Basic Science Research Program and the Multicenter National Prostate Cancer Database – and through a robust education and training program that operates out of its Headquarters location, the Clinical Research Center, and the original laboratories at USUHS. CPDR is also committed to patient outreach, primarily through its affiliation with the WRAMC US TOO! organization and through a heavy schedule of health fairs in which it participates.

To get started, find your selected interest below or use the blue navigation bar above.

CLINICIAN RESEARCHER PATIENTCPDR STAFF LISTING BY PROGRAMCPDR PARADIGM

> NEWS

WRAMC UsToo!

January 5, 2009

Our program for February 4, 2009, offers a change of pace from our usual program. In the past we have presented a panel of prostate cancer survivors who frankly described their individual experiences with various prostrate cancer treatments, then answered questions. This approach was well-received and we have had requests about having a similar program. So here it is!

Join us on Wednesday, February 4, 2009, at 7 PM in Joel Auditorium, Walter Reed Army Medical Center.
Your guests are always welcome.

This newsletter is published quarterly. Don't miss a single issue.

February 2009, Volume 18, Number 1

CPDR Offers Support Group
The Supportive Spouse
How You and Your Spouse Can Cope with Prostate Cancer

November 10, 2008

CPDR Patient Educator, Dr. Jane Hudak, offers to provide emotional support and information to the supportive spouses in our community who are affected by prostate cancer. The group offers frank discussion, support, information, sharing experiences, camaraderie and FUN!

Starting 14 January 2009

This women’s group meets the second Wednesday of each month
(right before the WRAMC Us TOO Support Group meeting)
1200 to 1300 hours
Center for Prostate Disease Research, Ward 56

Click Here For More Information

Read More News ...

Multi-center National Prostate Patient Database

Current Nomogram Predicting 5- and 10-year Overall Survival for Prostate Cancer (CaP) Patients

In 2006, CPDR launched its latest nomogram predicting 5- and 10-year overall survival for prostate cancer (CaP) patients who have undergone radical prostatectomy followed by a PSA recurrence. This tool demonstrates the importance of PSA doubling time in predicting time to death among CaP patients treated surgically.

These results were presented in an Abstract at the second annual American Society of Clinical Oncology (ASCO) Prostate Cancer Symposium, sponsored by ASCO, the Prostate Cancer Foundation, ASTRO, and the Society for Clinical Oncology (SUO).

Read Abstract

Go To Nomogram
(can only be viewed with IE 5.5 or higher)